{{medical}}
{{drugbox 
| IUPAC_name = [(1''R'',2''R'')-cyclohexane-1,2-diamine](ethanedioato-''O'',''O''')platinum(II)
| image = Oxaliplatin.svg | width = 200 px
| image2 = Oxaliplatin-3D-balls.png | width2 = 200 
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 	63121-00-6 
| PubChem = 77994 
| DrugBank = APRD00186 
| CAS_number2_Ref = {{cascite|changed|??}}
| CAS_number2 = 61825-94-3
| ATC_prefix = L01
| ATC_suffix = XA03
| ATC_supplemental =  
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank2 = DB00526
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 8062727
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 04ZR38536J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01790
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 414804
| PDB_ligand = 1PT
| C=8 | H=14 | N=2 | O=4 | Pt=1 
| molecular_weight = 397.2858 g/mol 
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = ~10 - 25 分钟 <ref>Ehrsson H, Wallin I, Yachnin J. ''Medical Oncology''. 2002; '''19''':251-265.</ref>
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 靜脈注射
| excretion = 肾 }}

'''奥沙利铂'''（Oxaliplatin），呈白色或类白色冻干疏松块状物，常用於转移性结直肠癌治疗，或辅助治疗原发性肿瘤完全切除后三期（Dukes C）[[结肠癌|结肠癌]]。

==作用機轉==
與[[順鉑|順鉑]]類似，水解後脫去[[草酸|草酸]]生成活性產物，然後與 [[DNA|DNA]]反應<ref name=Foye>{{Cite book | author =Thomas L. Lemke, David A. Williams | title =Foye's Principles of Medicinal Chemistry | location = USA |chapter=Cancer and Chemotherapy| publisher = LWW| date = 2012 | pages = 1199-1226 | ISBN = 978-1609133450 | accessdate = 2017-05-29  | language = en }} </ref>，活化路徑下圖，與[[DNA|DNA]]反應之機轉參考順鉑。
[[File:_Oxaliplatin_activation.svg|thumb]]

==参考资料==
{{reflist}}

{{化疗药物}}

[[Category:烷基化抗肿瘤剂|Category:烷基化抗肿瘤剂]]
[[Category:配位化合物|Category:配位化合物]]
[[Category:铂化合物|Category:铂化合物]]
[[Category:氨配合物|Category:氨配合物]]
[[Category:缺少物质图片的化学品条目|Category:缺少物质图片的化学品条目]]
[[Category:草酸根配合物|Category:草酸根配合物]]